OxThera (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Category:
Biotech Pharma
Business model:
B2B
Investors:
we tracked 9 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 5 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria.

OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria.

Companies with similar profile to OxThera:

CompanyCriteria
Sweden Asarina Pharma
65%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital, Kurma Life Science Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Athera
46%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden BoneSupport
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: HealthCap, Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden InDex Pharmaceuticals
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Denmark Blackwood Seven
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Sol Voltaics
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Apica
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Funnel
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Meniga
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Desentum
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Glucostratus (Mendor)
44%
  • Similar business models: B2B
  • At least one vc investor: LSP (Life Sciences Partners)
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Flatfrog
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Aurealis Pharma
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway poLight
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway BerGenBio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Peakon
43%
  • At least one vc investor: Sunstone Capital
  • At least one other investor: Idinvest Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes